These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2146989)

  • 1. Interleukin-2 receptor monoclonal antibodies have no effect on anti-CD3 monoclonal antibody-mediated cytotoxicity in CD3+ leukemic large granular lymphocytes.
    Yoon HJ; Aprile JA; Loughran TP
    Cell Immunol; 1990 Dec; 131(2):404-8. PubMed ID: 2146989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.
    Yoon HJ; Sugamura K; Loughran TP
    Leukemia; 1990 Dec; 4(12):848-50. PubMed ID: 2147047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2.
    Loughran TP; Draves KE; Starkebaum G; Kidd P; Clark EA
    Blood; 1987 Jan; 69(1):72-8. PubMed ID: 3098327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2-independent and -dependent components.
    Stohl W; Tovar Z; Talal N
    J Immunol; 1990 May; 144(10):3718-25. PubMed ID: 2139672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction between anti-CD3 and IL-2 demonstrated by proliferative response, interferon production, and non-MHC-restricted killing.
    Tovar Z; Dauphinée M; Talal N
    Cell Immunol; 1988 Nov; 117(1):12-21. PubMed ID: 2972393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12 is a costimulatory cytokine for leukemic CD3+ large granular lymphocytes.
    Gentile TC; Loughran TP
    Cell Immunol; 1995 Nov; 166(1):158-61. PubMed ID: 7585976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor-independent CD2 signal transduction in FcR+ cells.
    Arulanandam AR; Koyasu S; Reinherz EL
    J Exp Med; 1991 Apr; 173(4):859-68. PubMed ID: 1706751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the CD45 (T-200) molecule in anti-CD3-triggered T cell-mediated cytotoxicity.
    Deem RL; Shanahan F; Niederlehner A; Targan SR
    Cell Immunol; 1988 Nov; 117(1):99-110. PubMed ID: 2972397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different activation states of human lymphocytes after antibody-mediated stimulation via CD3 and the alpha/beta T-cell receptor.
    Schlitt HJ; Schwinzer R; Wonigeit K
    Scand J Immunol; 1990 Dec; 32(6):717-26. PubMed ID: 2148645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
    Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
    J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes.
    Aprile JA; Russo M; Pepe MS; Loughran TP
    Blood; 1991 Sep; 78(5):1282-5. PubMed ID: 1831681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45 ligation in T cells regulates signal transduction through both the interleukin-2 receptor and the CD3/Ti T-cell receptor complex.
    Gilliland LK; Schieven GL; Grosmaire LS; Damle NK; Ledbetter JA
    Tissue Antigens; 1990 Mar; 35(3):128-35. PubMed ID: 2142837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation by anti-CD2 monoclonal antibody of the activation of a human T cell clone induced by anti-CD3 or anti-T cell receptor antibodies.
    Yssel H; Aubry JP; de Waal Malefijt R; de Vries JE; Spits H
    J Immunol; 1987 Nov; 139(9):2850-5. PubMed ID: 2444643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between CD3 and Thy1 T cell activation pathways: blockade of CD3-mediated T lymphocyte activation induced by immobilized anti-Thy1 antibodies.
    Bellio M; Leal LM; Scharfstein J; Dos Reis GA
    Cell Immunol; 1991 Jul; 135(2):534-40. PubMed ID: 1674673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
    Ceuppens JL; Van Vaeck F
    Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific antibody-directed antitumor activity of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus interleukin 2.
    Nishimura T; Nakamura Y; Takeuchi Y; Gao XH; Tokuda Y; Okumura K; Habu S
    Jpn J Cancer Res; 1991 Nov; 82(11):1207-10. PubMed ID: 1836455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation.
    Stohl W; Crow MK
    Cell Immunol; 1990 Oct; 130(2):257-70. PubMed ID: 1976440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.